[e-drug] Out Patient Parenteral Antimicrobial Therapy (cont'd)

[Anibal Sosa <anibal.sosa@tufts.edu>]

E-drug: Out Patient Parenteral Antimicrobial Therapy (cont'd)
-------------------------------------------------------------------------

Dear all,

As a practicing physician in my native country Venezuela we used
Out Patient Parenteral Antimicrobial Therapy (OPAT) and not
necesarilly in patients that can not swallow, has acute GE with V&D,
etc. It is my understanding that they still do. In the general population
the OPAT is perceived as more effective than oral agents. If the
consideration is for IV administration, then there is more reluctancy.

Obviously physicians not only take into consideration that is a more
cost-effective practice that will reduce hospital admissions but also
that it is well received. It is a common practice.

I have research the topic and found these references on the Internet.
There are other links:
http://www.opat.com/default.htm
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showpro
ducts&Produk
tNr=224333&searchWhat=books
http://content.nejm.org/cgi/content/short/337/12/829
 
Anibal Sosa
Tufts University
USA
e-mail: anibal.sosa@tufts.edu

-------
Outpatient Parenteral Antimicrobial Therapy: Basic Reference List

ARTICLES

Tice AD, Hoaglund PA, Nolet B, et. al. Cost Perspective for
Outpatient Intravenous Antimicrobial Therapy. Pharmacotherapy.
2002 Feb;22(2 Pt 2):63S-70S.

Nathwani D, Tice A. Ambulatory antimicrobial use: the value of an
outcomes registry. J Antimicrob Chemother. 2002 Jan;49(1):149-154.

Tice AD, Nolet BR. Update on outpatient parenteral antimicrobial
therapy. Home Healthcare Consultant. 2001;8:22-29.

Andrews MM, von Reyn CF. Patient selection criteria and
management guidelines for outpatient parenteral antibiotic therapy for
native valve infective endocarditis. Clin Infect Dis. 2001;33:203-9.

Berman SJ, Johnson EW. Outpatient parenteral antibiotic therapy
(OPAT): clinical outcomes and adverse events. Hawaii Med J.
2001;20:19-24.

Bradley JS, Behrendt CE, Arrieta AC, et al. Convalescent phase
outpatient parenteral antiinfective therapy for children with
complicated appendicitis. Pediatr Infect Dis J. 2001;20:19-24. 

Esposito S. Treatment of lower respiratory tract infections in Italy: the
role of outpatient parenteral antibiotic therapy. Chemotherapy.
2001;47:33-40. 

Nathwani D. The management of skin and soft tissue infections:
outpatient parenteral antibiotic therapy in the United Kingdom.
Chemotherapy. 2001;47:17-23.

Tice AD. The use of outpatient parenteral antimicrobial therapy in the
management of osteomyelitis: data from the Outpatient Parenteral
Antimicrobial Therapy Outcomes Registries. Chemotherapy. 2001;
47:5-16.

Tice AD, Schleis TG, Nolet BN, et al. Outcomes registry for outpatient
IV antimicrobial therapy. Infusion 2000 May;6(7):27-35.

Dalovisio JR, Juneau J, Baumgarten K, Kateiva J. Financial impact of
a home intravenous antibiotic program on a medicare managed care
program. Clin Infect Dis. 2000, 30:639-42.

Tice AD. Pharmacoeconomic considerations in the ambulatory use of
parenteral cephalosporins. Drugs 2000; 59 Suppl 3:29-35.

Tice AD. Outpatient parenteral antibiotic therapy (OPAT) in the United
States: delivery models and indications for use. Can J Infect Dis
Jan/Feb 2000: 11A: 17A-21A. 

Tice AD. Medicare coverage of outpatient ambulatory intravenous
antibiotic therapy: a program that pays for itself. Clin Inf Dis Dec
1998; 27:1415-21. 

CHAPTERS

Tice AD. Outpatient intravenous antibiotic therapy. In: Mandell GL,
Bennett JE, Dolin R eds. Principles and Practices of Infectious
Diseases. 5 ed. Philadelphia: Churchill Livingston, Harcourt Health
Sciences: 2000: 546-50.

Tice AD. Home therapy with antibiotics. In: Armstrong D and Cohen J
eds. Infectious Diseases. Philadelphia: Mosby; 1999: 4.1-4.4.

Tice AD. Outpatient parenteral therapy of serious infections. In: Root
RK, Waldvogel F, Corey L, Stamm WE, eds. Clinical Infectious
Diseases: A Practical Approach. New York: Oxford University Press,
Inc.; 1999: 241-44.

BOOKLETS AND SUPPLEMENTS

Tice AD, Editor. Outpatient Parenteral Antimicrobial Therapy (OPAT):
A Global Perspective. Chemotherapy 2001;47. 

Tice AD, Editor. Outpatient Parenteral Antimicrobial Therapy.
Infectious Disease Clinics of North America. WB Saunders Company,
Philadelphia, PA. December 1998 12:4.

Tice AD. Handbook of Outpatient Parenteral Therapy for Infectious
Diseases, Scientific American, Inc., 1997 ($29.95 via Sci Am Med.,
415 Madison Avenue, New York, NY, Phone: 212-754-0860)

Tice AD, Editor. Outpatient Parenteral Antimicrobial Therapy: Current
Status. Scientific American Medicine Special Edition, July 1997.

Hoepelman IM. Outpatient Treatment with Parenteral Antimicrobial
Agents. International Journal of Antimicrobial Agents Supplement 5,
1995. 

Tice AD, Editor. Outpatient Parenteral Antibiotic Therapy -
Management of Serious Infections, Parts I&II. Hospital Practice
Symposium June and July, 1993.

ABSTRACTS 

Tice AD, Hoaglund PA, Schleis T, Kunkel M. Measuring outcomes
with Outpatient Parenteral Antimicrobial Therapy (OPAT). 4th
Decennial International Conference and Healthcare-Associated
Infections, Atlanta, GA. March 2000.

Martinelli LP, Tice AD, Hoaglund PA. Outpatient Parenteral
Antimicrobial Therapy (OPAT): bone and joint infections, and
outcomes analysis. IDSA 38th Annual Meeting, New Orleans, LA.
September 2000. 

Martinelli LP, Tice AD, Hoaglund PA. Outpatient Parenteral
Antimicrobial Therapy (OPAT): safety, efficacy, and outcomes. IDSA
38th Annual Meeting, New Orleans, LA. September 2000. 

Tice AD, Hoaglund PA. Outpatient Parenteral Antimicrobial Therapy
(OPAT) for acute and recurrent lung infections. ICAAC 40th Annual
Meeting, Toronto, Canada. September 2000.

Tice AD, Seibold G. Nathwani D. et al. Adverse effects with
intravenous antibiotic therapy. 11th European Congress of Clinical
Microbiology and Infectious Diseases (#P1307), Istanbul, Turkey,
April 4,2001 

Dall L, Paterson S, Simmons T, Harlow R. Aggressive home
treatment program (AHTP) for community-acquired pneumonia
(CAP). 39th Annual Meeting of IDSA. San Francisco, CA. October
25-28, 2001. 

Eron LJ, Eng J, King P, Marineau M. Early Discharge of patients with
cellulitis: comparison of ceftriaxone and cefazolin. 39th Annual
Meeting of IDSA. San Francisco, CA. October 25-28, 2001.

McNabb J, Freifeld AG, Yee GC, Brannan R. Economic outcomes of
outpatient treatment of low-risk febrile neutorpenia during cancer
chemotherapy. 39th Annual Meeting of IDSA. San Francisco, CA.
October 25-28, 2001. 

Quinn AL, Schroeder J, Yacoumakis P, O'Keefe P. A prospective
analysis of adverse drug reactions in patients receiving outpatient
intravenous antibiotics. 39th Annual Meeting of IDSA. San Francisco,
CA. October 25-28, 2001. 

Shrestha NK, Rehm SJ, Isada CM, Longworth DL. Rehospitalization
after discharge on community-based parenteral anti-infective therapy
(CoPAT). 39th Annual Meeting of IDSA. San Francisco, CA. October
25-28, 2001. 

Tice AD, Seibold GL, Martinelli LP, Shoultz D. Interactive,
computer-assisted, decision-making in antibiotic therapy. 39th Annual
Meeting of IDSA. San Francisco, CA. October 25-28, 2001. 

Tice AD, Seibold GL, Martinelli LP. Adverse effects from intravenous
antibiotics with OPAT. 40th Annual Meeting of IDSA, Chicago, IL,
October 25-27, 2002. 

Nathwani D, Seibold GL, Jones G, Esposito S, Tice AD. OPAT
Outcomes Registry evaluation of skin and soft tissue infections. 40th
Annual Meeting of IDSA, Chicago, IL, October 25-27, 2002. 

Wynn M, Dalovisio J, Chambers R. Efficacy and safety of outpatient
parenteral antimicrobial therapy (OPAT) for infections with
methicillin-sensitive Staphylococcus aureus (MSSA). 40th Annual
Meeting of IDSA, Chicago, IL, October 25-27, 2002.

OPAT Reference List (PDF)

OPAT Related Reference List (PDF)

Resources

NORTHWEST MANAGEMENT ASSOCIATES - Barbara Nolet, RN,
MA 

Consulting services for physician-directed OPAT program
2524 East Bay Drive, Gig Harbor,
Washington 98335
Phone (888) 367-6728, FAX (253)
853-2710, e-mail: bnolet@nwm-associates.com
Web: www.nwm-associates.com

OPIT SOURCE BOOK - Sheri Karanasos, Marketing Manager
The OPIT Source Book lists products and services for
providers of Outpatient IV Therapy services.
P.O. Box 1234, Tacoma, Washington
98401-1234
Phone (253) 756-7850, FAX (253)
272-8558, e-mail: infusion@opitsourcebook.com
Web: www.opitsourcebook.com

ID LINKS Web Page - http://www.idlinks.com/opat.htm
Contains the OPAT Outcomes Registries, additional
references to OPAT, plus other information regarding infectious
diseases and microbiology.
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug